Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 16, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
William Plovanic Maintained (ATRC) at Strong Buy with Decreased Target to $88 on, Feb 16th, 2022
William Plovanic of Canaccord Genuity, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Decreased Target from $120 to $88 on, Feb 16th, 2022.
William has made no other calls on ATRC in the last 4 months.
There is 1 other peer that has a rating on ATRC. Out of the 1 peers that are also analyzing ATRC, 0 agree with William's Rating of Hold.
This is the rating of the analyst that currently disagrees with William
- Danielle Antalffy of "SVB Leerink" Maintained at Buy with Increased Target to $110 on, Thursday, November 4th, 2021
